Jiangsu Lanfeng Bio-chemical Co Ltd

Jiangsu Lanfeng Bio-chemical Co Ltd exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 35.79 and total liabilities of 4,433,165,800 CNY, compared to total equity of 43,689,200 CNY. The company’s liquidity is constrained, as evidenced by a current ratio of 0.69 and negative operating cash flow of -376,002,660 CNY. The price-to-book ratio of 55.97 suggests market overvaluation relative to its tangible book value [doc:HA-latest]. Profitability is severely underperforming, with a net loss of -190,525,340 CNY and a return on equity of -4.36%. The company’s return on assets of -0.0426 and operating income of -284,112,180 CNY indicate operational inefficiencies. Gross profit of 55,182,240 CNY is insufficient to cover operating expenses, and the ev-to-ebitda of -14.11 reflects a lack of earnings power [doc:HA-latest]. The company operates through two segments: Agrochemical and Photovoltaic. Revenue concentration data is not disclosed, but the dual business model exposes it to both agricultural and renewable energy market dynamics. The Agrochemical segment is likely sensitive to commodity price fluctuations, while the Photovoltaic segment faces capital intensity and regulatory risks [doc:HA-latest]. Growth is under pressure, with a reported revenue of 2,342,107,170 CNY, below the analyst estimate of 1,481,392,130 CNY. The company’s capital expenditure of -144,912,190 CNY suggests ongoing investment in its photovoltaic operations, but free cash flow of -309,025,350 CNY indicates insufficient cash generation to fund operations or growth [doc:HA-latest]. The company faces medium liquidity risk due to negative operating cash flow and a current ratio below 1. The risk assessment flags net cash as negative after subtracting total debt. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. However, the company’s high leverage and negative equity raise concerns about long-term solvency [doc:HA-latest]. Recent financial filings show a deteriorating performance, with a net loss and negative cash flows. No recent earnings call transcripts or material events are disclosed, but the company’s exposure to both agrochemical and photovoltaic markets suggests sensitivity to global supply chain disruptions and regulatory changes in China [doc:HA-latest].